Christina Große-Thie

Author

Also Known As

C Große-Thie, C. Grosse-Thie, C. Große-Thie, CHRISTINA GROßE-THIE, Christina Grosse-Thie, Christina Grosse‐Thie, Christina Große-Thie, Große-Thie, Christina

Publications

712

Citations

H-Index

Concepts

All Affiliations

University of Rostock Jena University Hospital University Hospital Cologne University of Duisburg-Essen Friedrich-Alexander-Universität Erlangen-Nürnberg

About

Christina Große-Thie is an author at University of Rostock specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	266
2	Pharmacology	2	2	194
3	Allergy	1	1	10
4	Immunology	1	1	10
5	Pathology	1	1	29

Christina Große-Thie

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial Volker Kunzmann, Jens T. Siveke, Hana Algül, The Lancet. Gastroenterology & hepatology Pancreatic CancerGastrointestinal OncologyMedicinePharmacologyPharmacotherapy	2020	184
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes, The Lancet Haematology	2019	147
Longitudinal observation of anxiety and depression among palliative care cancer patients Corinna Sewtz, Wiebke Muscheites, Christina Große-Thie, Annals of Palliative Medicine	2021	62
AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial Stephanie Sasse, Paul J. Bröckelmann, Jesko Momotow, Leukemia & lymphoma/Leukemia and lymphoma	2022	52
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) Johanna Inhestern, Harald Schmalenberg, Andreas Dietz, Annals of Oncology Surgical OncologyPostoperative RadiotherapyMedicineSurgerySplit Tpf	2017	43
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) Konrad Klinghammer, Thomas Gauler, Andreas Dietz, European Journal of Cancer Aio/iag-kht Trial 1108Open-label Phase IiMedicinePathologyHead And Neck Cancer	2019	29
Feasibility and Effects of a Supervised Exercise Program Suitable for Independent Training at Home on Physical Function and Quality of Life in Head and Neck Cancer Patients: A Pilot Study Sabine Felser, Martin Behrens, Jan Liese, Integrative Cancer Therapies	2020	24
Questionnaires measuring quality of life and satisfaction of patients and their relatives in a palliative care setting—German translation of FAMCARE-2 and the palliative care subscale of FACIT-Pal Corinna Sewtz, Wiebke Muscheites, Ursula Kriesen, Annals of Palliative Medicine	2018	17
Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies Daniel Strüder, Theresa Momper, Nina Irmscher, Journal of Experimental & Clinical Cancer Research	2021	16
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer Markus Hecht, D Hahn, Philipp Wolber, BMC Cancer	2020	14

Page 1